Salivary proteomics in monitoring the therapeutic response of canine oral melanoma
Open Access
- 19 August 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0256167
Abstract
Saliva biomarkers are suitable for monitoring the therapeutic response of canine oral melanoma (COM), because saliva directly contacts the tumor, and saliva collection is non-invasive, convenient and cost effective. The present study aimed to investigate novel biomarkers from the salivary proteome of COM treated with surgery and a chemotherapy drug, carboplatin, 1–6 times, using a liquid chromatography–tandem mass spectrometry approach. The expression of a potential salivary biomarker, ubiquitin D (UBD), was observed and verified by western blot analysis. A significantly increased ratio of free UBD (fUBD) to conjugated UBD (cUBD) was shown in the pre-surgery stage (PreS) in OM dogs with short-term survival (STS) (less than 12 months after surgery) compared with that with long-term survival (more than 12 months after surgery). In dogs with STS, the ratio was also shown to be augmented in PreS compared with that after surgery, followed by treatment with carboplatin twice, 4 and 5 times [After treatment (AT)2, AT4 and AT5]. In addition, the expression of fUBD was enhanced in PreS compared with that of AT2 in the STS group. In conclusion, this study revealed that a ratio of fUBD to cUBD in PreS was plausibly shown to be a potential prognostic biomarker for survival in dogs with OM.Keywords
Funding Information
- Thailand Research Fund (RSA5980053)
- The 100th Anniversary Chulalongkorn University for Doctoral Scholarship
- the 90th Anniversary of Chulalongkorn University Scholarship
This publication has 33 references indexed in Scilit:
- What are biomarkers?Current Opinion in HIV and AIDS, 2010
- Ubiquitin becomes ubiquitous in cancerCancer Biology & Therapy, 2010
- Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgeryBritish Journal of Cancer, 2010
- Proteomic identification and profiling of canine lymphoma patients*Veterinary and Comparative Oncology, 2009
- Proteomic identification and profiling of canine lymphoma patientsVeterinary and Comparative Oncology, 2009
- Metronomic Therapy with Cyclophosphamide and Piroxicam Effectively Delays Tumor Recurrence in Dogs with Incompletely Resected Soft Tissue SarcomasJournal of Veterinary Internal Medicine, 2008
- Proteomic analysis of dog tears for potential cancer markersResearch in Veterinary Science, 2008
- Evaluation of sample fractionation using micro‐scale liquid‐phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experimentRapid Communications in Mass Spectrometry, 2007
- Differential expression analysis of Escherichia coli proteins using a novel software for relative quantitation of LC‐MS/MS dataProteomics, 2006
- Drug discovery in the ubiquitin–proteasome systemNature Reviews Drug Discovery, 2006